QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus

Stroke

Volumn 34, Issue 9, 2003, Pages 2187-2194

  Cardoso, Claudia R L ^a   Salles, Gil F ^a   Deccache, Waldemar ^a  

^a NONE

Author keywords

Diabetes mellitus; Electrocardiography; Risk factors; Stroke

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; KAPLAN MEIER METHOD; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; QT INTERVAL; RISK ASSESSMENT; RISK FACTOR; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME;

EID: 0041416156     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000085084.15144.66     Document Type: Article

References (38)

1. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001;32:280-299.
2. Mansur AP, Favarato D, Souza MFM, Avakian SD, Aldrighi JM, César LAM, Ramires JAF. Trends in death from circulatory diseases in Brazil between 1979 and 1996. Arq Bras Cardiol. 2001;76:504-510.
3. Manolio TA, Kronmal RA, Burke GL, O'Leary DH, Price TR. Short-term predictors of incident stroke in older adults: the Cardiovascular Health Study. Stroke. 1996;27:1479-1486.
4. Tanne D, Yaari S, Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) project. Circulation. 1998;98:1365-1371.
5. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the Elderly. Stroke. 1998;29:1341-1346.
6. Moons KGM, Bots ML, Salonen JT, Elwood PC, Freire de Gonçalves A, Nikitin Y, Sivenius J, Inzitari D, Benetou V, Tuomilehto J, et al. Prediction of stroke in the general population in Europe (EUROSTROKE): is there a role for fibrinogen and electrocardiography? J Epidemiol Community Health. 2002;56(suppl 1):I30-I36.
7. Manson JAE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141-1147.
8. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population. Stroke. 1996;27:210-215.
9. Elneihoum AM, Goransson M, Falke P, Janzon L. Three-year survival and recurrence after stroke in Malmo, Sweden: an analysis of stroke registry data. Stroke. 1998;29:2114-2117.
10. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke. 1996;27:63-68.
11. Davis TM, Millns H, Stratton IM, Holman RR, Turner RC. Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med. 1999;159:1097-1103.
12. Fuller JH, Stevens LK, Wang S-L, for the WHO Multinational Study Group. Risk factors for cardiovascular mortality and morbidity: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44(suppl 2):S54-S64.
13. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB. Impaired fasting glucose, diabetes mellitus and cardiovascular disease risk factors are associated with prolonged QTc duration: results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk. 2001;8:227-233.
14. Elming H, Holm E, Jun L, Torp-Pedersen C, Køber L, Kircshoff M, Malik M, Camm J. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J. 1998;19:1391-1400.
15. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly: the Rotterdam Study. Eur Heart J. 1999;20:278-284.
16. Naas AAO, Davidson NC, Thompson C, Cummings F, Ogston AS, Jung RT, Newton RW, Struthers AD. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin-dependent diabetes: cohort study. BMJ. 1998;316:745-746.
17. Christensen PK, Gall MA, Major-Pedersen A, Sato A, Rossing P, Breum L, Pietersen A, Kastrup J, Parving HH. QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest. 2000;60:323-332.
18. Cardoso C, Salles G, Deccache W. Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. J Diabetes Complications. 2003;17:169-178.
19. Cardoso C, Salles G, Bloch K, Deccache W, Siqueira-Filho AG. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int J Cardiol. 2001;79:253-262.
20. Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1985. Technical Report Series.
21. Devereux RB, Reichek N. Echocardiograhic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
22. Levy D, Savage DD, Garrison J, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;59:956-960.
23. Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders. Stroke-1989: recommendations on stroke prevention, diagnosis and therapy. Stroke. 1989;20:1407-1431.
24. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analysis. Am J Epidemiol. 1995;142:1255-1264.
25. Concato J, Feinstein AR, Holford TR. The risk of determining risk in multivariate models. Ann Intern Med. 1993;118:201-210.
26. Rautaharju PM, Manolio TA, Psaty BM, Borhani NO, Furberg CD, for the Cardiovascular Health Study Collaborative Research Group. Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Am J Cardiol. 1994;73:999-1002.
27. Festa A, D'Agostino R Jr, Rautaharju P, Mykkänen L, Haffner SM. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol. 2000;86:1117-1122.
28. Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J, Kromhout D. QTc duration is associated with levels of insulin and glucose tolerance: the Zutphen Elderly Study. Diabetes. 1996;45:376-380.
29. Whitsel EA, Boyko EJ, Siscovick DS. Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes. Diabetes Care. 2000;23:241-247.
30. Ko GT, Chan JC, Critchley JA, Cockram CS. Cardiovascular disease in Chinese type 2 diabetic women is associated with a prolonged QTc interval. Int J Cardiol. 2000;76:75-80.
31. Veglio M, Bruno G, Borra M, Macchia G, Bargero G, D'Errico N, Pagano GF, Cavallo-Perin P. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med. 2002;251:317-324.
32. Okin PM, Devereux RB, Howard BV, Fabsitz RR, Lee ET, Welty TK. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: the Strong Heart Study. Circulation. 2000;101:61-66.
33. Sawicki PT, Kiwitt S, Bender R, Berger M. The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med. 1998;243:49-56.
34. Festa A, D'Agostino R, Rautaharju P, O'Leary DH, Rewers M, Mykkänen L, Haffner SM. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1999;30:1566-1571.
35. Rutter MK, Viswanath S, McComb JM, Kesteven P, Marshall SM. QT prolongation in patients with type 2 diabetes and microalbuminuria. Clin Auton Res. 2002;12:366-372.
36. Perkiomaki JS, Sourander LB, Levomaki L, Raiha IJ, Puukka P, Huikuri HV. QT dispersion and mortality in the elderly. Ann Noninvasive Electrocardiol. 2001;6:183-192.
37. Guerrero-Romero F, Rodriguez-Moran M. Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus. Stroke. 1999;30:1787-1791.
38. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298:789-794.